Global map > Innovations > Western Europe > Germany > Munich > InflaRx N.V.
InflaRx N.V. icon
InflaRx N.V. is testing IFX-1, a monoclonal anti-human complement factor C5a antibody currently under development as treatment for inflammatory conditions and COVID-19 pneumonia.
Rankings by SemRush
National Ranking
41st
in Germany
Regional Ranking
318th
in Western Europe
Global Ranking
1450th
worldwide
Loading startups...